GenoGenix recalls 20 mg and 20 mg/mL 10mL Semaglutide injections due to lack of sterility assurance. Affected lots from GG021125-001 to GG031125-017.
Lack of Assurance of Sterility
GenoGenix is recalling 20 mg and 20 mg/mL 10mL Semaglutide injections because they may not be sterile. This could lead to infections if used.
The product lacks assurance of sterility, meaning it might contain harmful bacteria. If injected, this could cause serious infections or health issues.
People who have the recalled Semaglutide injections from GenoGenix. Those using the product for weight loss or diabetes treatment are most at risk.
Check for the brand GenoGenix on the vial label. The product is labeled as 20 mg or 20 mg/mL, 10 mL multi-dose vials. Lot numbers GG021125-001 to GG031125-017 are affected.
Look for the brand name GenoGenix and product details on the vial label.
The product may not be sterile, which could lead to infections if used.
Lots GG021125-001 to GG031125-017.
The recall does not specify a stop-use action, so you should check the label and contact GenoGenix if unsure.
We’ve drafted a message you can send GenoGenix to request your refund or repair — edit it as you like.
Subject: Recall D-0091-2026 — GenoGenix GenoGenix Hello, I own a GenoGenix that is covered by recall D-0091-2026 from GenoGenix. I’m writing to arrange the remedy described in the recall (a refund, repair, or replacement as applicable). Could you please tell me the next steps to resolve this? Thank you.
Experiences, tips, and questions from readers. Every comment is reviewed before it appears.
No comments yet — be the first to share your experience.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
